US Government Pledges $144M to Anti-Aging Research via ARPA-H's PROSPR Initiative
【Abstract】: (Tech & Funding Milestone) Breaking news on February 25, 2026: The US Advanced Research Projects Agency for Health (ARPA-H) announced a massive commitment of up to $144 million over five years to fund anti-aging research. The new initiative, called PROSPR (PROactive Solutions for Prolonging Resilience), awards contracts to seven elite teams focused on extending "healthspan" and reversing biological age. Economists estimate that reversing national biological age by just one year could unlock $38 trillion in economic value.
Business Insight: Government-backed funding at this scale fundamentally shifts "longevity" from a niche biotech sector into mainstream healthcare infrastructure. For B2B investors and high-end longevity clinics attending CMTF, this validates the immediate commercialization of cellular therapies and biological age diagnostics, moving the industry toward a highly regulated, massively profitable future.
【Keywords】: #LongevityTech #AntiAging #BiotechInvestment
【Source Link】: Fierce Biotech - ARPA-H designates $144M for anti-aging research (Feb 25, 2026)
